Back to top

H.C. Wainwright Keeps Their Buy Rating on NRX Pharmaceuticals (NRXP)

In a report released today, Patrick Trucchio from H.C. Wainwright reiterated a Buy rating on NRX Pharmaceuticals, with a price target of $45.00. Tr...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

NRx Pharmaceuticals, Inc. (NRXP)